Preoperative CEA (HR: 1.12; 95% CI: 1.03–1.22, p = 0.02), preoperative CA19-9 (HR: 1.09; 95% CI: 1.01–1.18, p = 0.03), and tumor stage (HR: 1.30; 95% CI: 1.08–1.50, p = 0.01) were significant prognostic factors. This evidence concerns the gene CEACAM5 and neoplasm.